| Korea-UK Collaborative Seminar 2022 (e-Conference) | ||||
| Cell therapy for cardiovascular disease - what’s next? | ||||
| Friday 28 October 2022, 8:00-10:35am UK / 4:00-6:35pm Korea | ||||
| Time (UK) | Time (Korea) | Duration | Title | Speaker |
| 8:00-8:05 | 4:00-4:05 | 5 min. | Introduction | |
| 8:00-8:05 | 4:00-4:05 | 5 min. |
Opening Remarks
Prof. Myung Ho Jeong (Chonnam National University Hospital, Korea)
 |
|
|
Welcoming address
Prof. Youngkeun Ahn (President and CEO of Chonnam National University Hospital, Korea)
|
||||
| 8:05-9:15 | 4:05-5:15 | 70 min. | Session 1. Methods of cell-based therapy | |
| Chairs: | Prof. Amrita Ahluwalia (Queen Mary University of London, UK)  Prof. Myung Ho Jeong (Chonnam National University Hospital, Korea) |
|||
| 8:05-8:15 | 4:05-4:15 | 10 min. |
Cell delivery methods: Life after NOGA
Anthony Mathur (Queen Mary University of London, UK)
| |
| 8:15-8:25 | 4:15-4:25 | 10 min. |
Is there an ideal cell type?
Philippe Menasché (Université Paris Cité, France)
 |
|
| 8:25-8:35 | 4:25-4:35 | 10 min. |
Bioengineering/scaffolds – the role of cells
Doo Sun Sim (Chonnam National University Hospital, Korea)
|
|
| 8:35-8:45 | 4:35-4:45 | 10 min. |
How close are we to a biological total artificial heart?
Doris Taylor (CEO of Organamet Bio, Inc., USA)
 |
|
| 8:45-8:55 | 4:45-4:55 | 10 min. |
Are cells alone enough?
Stefanie Dimmeler (Goethe University, Frankfurt Am Main, Germany)
|
|
| 8:55-9:05 | 4:55-5:05 | 10 min. |
Cell transitions in cardiovascular disease
Yong Sook Kim (Chonnam National University Hospital, Korea)
|
|
| 9:05-9:15 | 5:05-5:15 | 10 min. |
Discussion
Young Joon Hong (Chonnam National University Hospital, Korea)
Dae Sung Park (Chonnam National University Hospital, Korea) Joon Ho Ahn (Chonnam National University Hospital, Korea) Daniel A. Jones (Queen Mary University of London, UK)
|
|
| 9:15-10:15 | 5:15-6:15 | 60 min. | Session 2: Disease targets for cell-based therapy | |
| Chairs: | Prof. Anthony Mathur (Queen Mary University of London, UK) Prof. Youngkeun Ahn (Chonnam National University Hospital, Korea) |
|||
| 9:15-9:25 | 5:15-5:25 | 10 min. |
Cell therapy for acute myocardial infarction - the end of a chapter?
Peter-Paul Zwetsloot (University of Utrecht, The Netherlands)
 | |
| 9:25-9:35 | 5:25-5:35 | 10 min. |
Refractory angina
Tim Henry (The Christ Hospital, USA)
| |
| 9:35-9:45 | 5:35-5:45 | 10 min. |
Ischaemic heart failure
Emerson Perin (Texas Heart Institute, USA)
| |
| 9:45-9:55 | 5:45-5:55 | 10 min. |
Dilated cardiomyopathy
Bojan Vrtovec (UMC Ljubljana, Slovenia)
 | |
| 9:55-10:05 | 5:55-6:05 | 10 min. |
Precision cell therapy - what should we target?
Mariann Gyöngyösi (Medical University of Vienna, Austria)
 | |
| 10:05-10:15 | 6:05-6:15 | 10 min. |
Discussion
Ju Han Kim (Chonnam National University Hospital, Korea)
Kye Hun Kim (Chonnam National University Hospital, Korea) Jae Yeong Cho (Chonnam National University Hospital, Korea) John Martin (University College London, UK)
|
|
| 10:15-10:30 | 6:15-6:30 | 15 min. | Keynote lecture | |
| 10:15-10:30 | 6:15-6:30 | 15 min. |
What’s next for the field?
Giulio Pompilio (Centro Cardiologico Monzino, Italy)
| |
| 10:30-10:35 | 6:30-6:35 | 5 min. | Close | |
| 10:30-10:35 | 6:30-6:35 | 5 min. |
Closing remarks
Anthony Mathur (Queen Mary University of London, UK)
| |
